Breathe BioMedical Inc. (BRTH)

Breathe BioMedical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022
Debt / Equity Ratio	19.10	1.84	2.66
Debt / EBITDA Ratio	-	-0.24	-0.29
Debt / FCF Ratio	-0.47	-0.37	-0.35
Quick Ratio	-	1.20	0.98
Interest Coverage	-	-516.73	-
Return on Equity (ROE)	-6075.51%	-797.11%	-963.86%
Return on Assets (ROA)	-	-176.03%	-132.36%
Return on Capital (ROIC)	-325.59%	-308.17%	-319.30%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).